https://www.indianpharmapost.com/biocon-concludes-a-rs-4500-crore-equity-fundraise-through-qip-172922025-06-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbvie-announces-new-data-demonstrating-atogepant-achieves-superiority-in-phase-3-study-172932025-06-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/roches-lunsumio-and-polivy-combination-significantly-prolongs-remission-for-people-with-relapsed-or-refractory-large-b-cell-lymphoma-172942025-06-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/biogen-initiates-phase-3-pediatric-study-of-omaveloxolone-for-treatment-of-friedreich-ataxia-172952025-06-21T00:00:00+05:30always0.9